These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials. Vidal L; Gafter-Gvili A; Salles G; Dreyling MH; Ghielmini M; Hsu Schmitz SF; Pettengell R; Witzens-Harig M; Shpilberg O J Natl Cancer Inst; 2011 Dec; 103(23):1799-806. PubMed ID: 22021664 [TBL] [Abstract][Full Text] [Related]
6. Rituximab maintenance therapy until progression after rituximab and chemotherapy induction in patients with follicular lymphoma. Yared J; Kimball A; Baer MR; Bahrain H; Auerbach M Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):253-7. PubMed ID: 23352637 [TBL] [Abstract][Full Text] [Related]
7. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study. Askeland G Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446 [No Abstract] [Full Text] [Related]
9. Rituximab by subcutaneous route. Solal-Celigny P Expert Rev Hematol; 2015 Apr; 8(2):147-53. PubMed ID: 25749209 [TBL] [Abstract][Full Text] [Related]
10. [Malignant lymphoma: individualized treatment according to biological and clinical risk factors]. Dreyling M Dtsch Med Wochenschr; 2011 Apr; 136(14):687-90. PubMed ID: 21448827 [No Abstract] [Full Text] [Related]
11. Rituximab maintenance in indolent lymphoma: indications and controversies. van Oers MH Curr Oncol Rep; 2007 Sep; 9(5):378-83. PubMed ID: 17706166 [TBL] [Abstract][Full Text] [Related]
12. 'Watch and wait' as initial management for patients with follicular lymphomas: still a viable strategy? Hagemeister FB BioDrugs; 2012 Dec; 26(6):363-76. PubMed ID: 23057946 [TBL] [Abstract][Full Text] [Related]
13. What is the role of maintenance rituximab in follicular NHL? Maloney DG Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281 [TBL] [Abstract][Full Text] [Related]
14. Conjunctival and orbital lymphoma. Shinder R Ophthalmology; 2011 Aug; 118(8):1692; author reply 1692, 1692.e1. PubMed ID: 21813098 [No Abstract] [Full Text] [Related]
16. Rituximab as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma: profile report. Croxtall JD BioDrugs; 2011 Oct; 25(5):329-31. PubMed ID: 21942917 [No Abstract] [Full Text] [Related]
17. Rituximab for the treatment of follicular lymphoma. Cheah CY; Lingaratnam S; Seymour JF Future Oncol; 2013 Sep; 9(9):1283-98. PubMed ID: 23980675 [TBL] [Abstract][Full Text] [Related]
18. [Subcutaneous administration of MabThera for therapy of non-Hodgkin lymphomas frees patients and medical personnel]. Pflege Z; 2013 Apr; 66(4):253. PubMed ID: 23634557 [No Abstract] [Full Text] [Related]
19. The withdrawal of drugs for commercial reasons: the incomplete story of tositumomab. Prasad V JAMA Intern Med; 2014 Dec; 174(12):1887-8. PubMed ID: 25383420 [No Abstract] [Full Text] [Related]
20. Follicular lymphoma, survival, and rituximab: is it time to declare victory? Horning SJ J Clin Oncol; 2008 Oct; 26(28):4537-8. PubMed ID: 18662966 [No Abstract] [Full Text] [Related] [Next] [New Search]